Non-Myeloablative Conditioning and Bone Marrow Transplantation

NCT01850108 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Hemoglobinopathies

Interventions

DRUG: Thymoglobulin
DRUG: Fludarabine
DRUG: Cyclophosphamide (CTX)
DRUG: Mesna
DRUG: Sirolimus
DRUG: Mycophenolate mofetil (MMF)
PROCEDURE: Bone marrow transplantation
RADIATION: Total body irradiation

Sponsor

Vanderbilt-Ingram Cancer Center